Study Group: Biopharmaceutical Pricing Trend Experts (US)
Council Members in this Study Group: 24
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
Adam Fein, PhDFounder & President
PEMBROKE CONSULTING INC
Adam Fein, PhD, is the Founder and President of Pembroke Consulting, Inc., a Philadelphia-based management advisory and business research firm. Dr. Fein is one of the country’s foremost experts on pharmacy economics and the pharmaceutical supply chain. He provides strategic advisory services to a diverse...
- Vikram Singh, MBA
Director in Health and Productivity Practice
Buck Consultants, LLC. (Mellon Consultants)Vikram Singh, MBA, is the Director in the Health and Productivity Practice at Buck Consultants. His expertise is in the financial and business aspects of pharmacy benefit management. Mr. Singh provides strategic advice in the areas of pharmacy benefit and health care finance, and on mergers and acquisitions...
Dea Belazi, PharmD, MPH, PAHMPharmacy Consultant
Dea Belazi, PharmD, MPH, PAHMDea Belazi, PharmD, MPH, PAHM, is currently a Consultant working with health plans and pharmaceutical companies. Dr. Belazi is also a Consulting Practice Leader for Wolters Kluwer Health- Managed Care Group. Previously, he was the Senior Director of Pharmacy Services for Independence Blue Cross, alarge...
Steven Miller, MS, DPHPresident
Steven Miller, MS, DPHSteven Miller, MSPharm, DPH, is the President and Chief Executive Officer of SJM Enterprises, a multi-faceted consumer-response organization, specializing in workers compensation, medication therapy management, and managed care pharmaceutical reimbursement issues, where he is working since February...
Tim Gallagher, RPhExecutive Vice President of Pharmacy Operations
ASTRUP DRUG, INC.Tim Gallagher, RPh, is the Executive Vice President of Pharmacy Operations at Astrup Drug in Minnesota, since 1999. Mr. Gallagher manages all aspects of pharmacy operations for the company. He has been a practicing pharmacist for over 25 years in both the chain and independent community pharmacy setting...
GLG NewsSM Analyses by this Study Group's Leading Experts (?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
No Visible Revenue Synergies in CVS Caremark's Latest Numbers
February 23, 2009
Adam Fein, PhD, Founder & President, PEMBROKE CONSULTING INC
CVS Net Rises; Finance Chief Plans to Retire | online.wsj.com
CVS Caremark’s PBM businesses are not becoming a larger share of prescriptions filled at CVS retail pharmacies. Put another way, the flagship Maintenance Choice program may be appealing to payers and consumers, but there is not yet a quantitatively visible shift in CVS' retail activity. If CVS pharmacies...
-
January 16, 2009
Adam Fein, PhD, Founder & President, PEMBROKE CONSULTING INC
Health-Care Outlays Climb at Slowest Rate in Years | online.wsj.com
U.S. spending on outpatient prescription drugs grew by only 4.9 percent in 2007, which was below overall health care spending growth of 6.1 percent. Public funds (primarily Medicare and Medicaid) paid for 36 percent of total retail prescription drug spending in 2007. So, how much money do pharmacies...
-
An Unfortunate Victory for EU Repackagers
December 9, 2008
Adam Fein, PhD, Founder & President, PEMBROKE CONSULTING INC
EU Exec Drops Drug Repackaging Ban Plan | www.reuters.com
Reuters reported on Friday that the EU plans to drop a proposed ban on repackaging of pharmaceuticals. In my opinion, dropping the ban is a very bad decision. Repackaging eliminates the benefit of just about every practical anti-counterfeit tracking technology, including the emerging serializationrequirements...
-
Cardinal Health Rebuilds Reputation with DEA Compliance Efforts
December 8, 2008
Adam Fein, PhD, Founder & President, PEMBROKE CONSULTING INC
Cardinal Health Builds Out its 'Suspicious Order Monitoring Program' | pharmaceuticalcommerce.com
Now that Cardinal Health (CAH) has finally resolved its long-standing DEA issues, the company has quietly launched a series of intriguing Medication Safety web pages. I’m impressed by these initial public efforts at education and greater transparency, although it’s obviously a work-in-progress. Cardinal...
-
Pharmacy Groups Oppose First Databank AWP Settlement
December 3, 2008
Adam Fein, PhD, Founder & President, PEMBROKE CONSULTING INC
NACDS and FMI filed another brief in opposition to the controversial proposed First Databank settlement, although they overstate their arguments in a few places. I expect this battle to heat up over the next month as we get closer to the late December hearing about First Databank’s settlement. This...
Members in this Study Group include these company types:
- Consultancy, Pharma-Focused
- Healthcare Management
- Pharmacy or Drug Store, Chain
- Managed Care Health Insurer, For-Profit
- Pharmaceuticals Manufacturer
- Biotechnology Manufacturer
- Consultancy, Healthcare-Focused
- Drug Distributor, General or Full-Spectrum
- Individual/Small Consultancy
- Lab, Non-Academic/Community Hospital
- Laboratory, Independent
- Pharmaceutical Benefits Manager, Large >10 M Lives
- Pharmaceutical Benefits Manager, Small <10 M Lives
- Pharmaceutical Software, IT & Other
- Third Party Administrator
Members in this Study Group often have these job titles:
- Director
- Business Development Manager
- President
- Owner
- Senior Vice President
- Medical Director
- Chief Executive Officer
- Manager
- Pharmacist - RPh/PharmD
- Principal
- Regional Sales Manager
- Consultant
- Marketing Director
- Operations Executive
- Partner
Related Study Groups
GLG Live Meetings with this Study Group's Leading Experts (?)
Upcoming Seminars
Leading Experts in Biopharmaceutical Pricing Trend Experts (US) Study Group have not participated in any upcoming seminars.
View All GLG Live Meetings in Healthcare
GLG Webcasts
Leading Experts in Biopharmaceutical Pricing Trend Experts (US) have not participated in any GLG webcasts.